Unknown

Dataset Information

0

Methylation levels of the "long interspersed nucleotide element-1" repetitive sequences predict survival of melanoma patients.


ABSTRACT: BACKGROUND: The prognosis of cutaneous melanoma (CM) differs for patients with identical clinico-pathological stage, and no molecular markers discriminating the prognosis of stage III individuals have been established. Genome-wide alterations in DNA methylation are a common event in cancer. This study aimed to define the prognostic value of genomic DNA methylation levels in stage III CM patients. METHODS: Overall level of genomic DNA methylation was measured using bisulfite pyrosequencing at three CpG sites (CpG1, CpG2, CpG3) of the Long Interspersed Nucleotide Element-1 (LINE-1) sequences in short-term CM cultures from 42 stage IIIC patients. The impact of LINE-1 methylation on overall survival (OS) was assessed using Cox regression and Kaplan-Meier analysis. RESULTS: Hypomethylation (i.e., methylation below median) at CpG2 and CpG3 sites significantly associated with improved prognosis of CM, CpG3 showing the strongest association. Patients with hypomethylated CpG3 had increased OS (P = 0.01, log-rank = 6.39) by Kaplan-Meyer analysis. Median OS of patients with hypomethylated or hypermethylated CpG3 were 31.9 and 11.5 months, respectively. The 5 year OS for patients with hypomethylated CpG3 was 48% compared to 7% for patients with hypermethylated sequences. Among the variables examined by Cox regression analysis, LINE-1 methylation at CpG2 and CpG3 was the only predictor of OS (Hazard Ratio = 2.63, for hypermethylated CpG3; 95% Confidence Interval: 1.21-5.69; P = 0.01). CONCLUSION: LINE-1 methylation is identified as a molecular marker of prognosis for CM patients in stage IIIC. Evaluation of LINE-1 promises to represent a key tool for driving the most appropriate clinical management of stage III CM patients.

SUBMITTER: Sigalotti L 

PROVIDER: S-EPMC3123580 | biostudies-literature | 2011

REPOSITORIES: biostudies-literature

altmetric image

Publications

Methylation levels of the "long interspersed nucleotide element-1" repetitive sequences predict survival of melanoma patients.

Sigalotti Luca L   Fratta Elisabetta E   Bidoli Ettore E   Covre Alessia A   Parisi Giulia G   Colizzi Francesca F   Coral Sandra S   Massarut Samuele S   Kirkwood John M JM   Maio Michele M  

Journal of translational medicine 20110526


<h4>Background</h4>The prognosis of cutaneous melanoma (CM) differs for patients with identical clinico-pathological stage, and no molecular markers discriminating the prognosis of stage III individuals have been established. Genome-wide alterations in DNA methylation are a common event in cancer. This study aimed to define the prognostic value of genomic DNA methylation levels in stage III CM patients.<h4>Methods</h4>Overall level of genomic DNA methylation was measured using bisulfite pyrosequ  ...[more]

Similar Datasets

| S-EPMC3660504 | biostudies-literature
| S-EPMC3699298 | biostudies-literature
| S-EPMC4803746 | biostudies-literature
| S-EPMC1301596 | biostudies-literature
| S-EPMC3529008 | biostudies-literature
| S-EPMC4432828 | biostudies-literature
2015-08-26 | GSE60784 | GEO
| S-EPMC3080381 | biostudies-literature
| S-EPMC1182203 | biostudies-literature
| S-EPMC5063351 | biostudies-literature